Search

everythinglearnresearchcommunity

for

Search:↓

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

More research is needed to understand how testosterone is maintained in adult males.

The free androgen index varies among women with different types of PCOS.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Most women with PCOS have insulin resistance, especially those with phenotype B.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Tea, especially green tea, shows promise in cosmetics for skin and hair benefits but more research is needed for effective use.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

Eating healthy and exercising can help manage Polycystic Ovarian Syndrome and its related health problems.

Resistance training might help with PCOS symptoms, but more research is needed.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Healthcare providers should start with simple fertility tests and treatments before referring patients to specialists.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Women with PCOS are much more likely to have sleep problems and should be checked for them.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.